… discuss how a deep insight into the physical and biological characteristics of biofilms can
inform therapeutic strategies and molecular targets for the development of anti-biofilm drugs. …

… The interval between initiation of therapy with etanercept or infliximab and the development
of … -TNF treatment, in the absence of specific cytotoxic therapy directed toward the lymphoma. …

… The development of drug-loading technology will bring new and rapid development to the
treatment of diseases. At present, drug delivery by nanoparticles, erythrocyte, and platelet …

… in drug design can have a profound impact on drug synergism and antagonism. A systematic
combination therapy development … drug dose ratios that result in globally optimal treatment …

… It is likely that syndromes such as Alzheimer’s disease will require multiple drug therapy to
… of combining drugs with different therapeutic targets is workable, the development of multi…

In the past two decades a trickle of manuscripts examining the non-neuronal central nervous
system immune consequences of the drugs of abuse has now swollen to a significant body …

… comparison to other therapeutic areas. Current data suggest that drug development, from the
… This familiar statistic prompts an equally familiar question: can the therapeutic development …

… immunodeficiency virus type 1 (HIV-1), drug therapy has been used widely in the treatment
of AIDS. The loss of the therapeutic effect of zidovudine as a result of the acquisition of …

… for the treatment of NASH; however, no single therapy has been approved so far. Due to
the increasing prevalence and the health burden, there is a high need to develop therapeutic …

… drug development strategy is exploration of drugs that have already been approved for
treatment of … [ 2 ] The process of finding new uses of existing drugs (marketed drugs and failed or …